3 completed, 3 recruiting, 2 unknown. 4 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Recruiting 2 |
| Phase 3 | 2 | Unknown 2 |
Follow Chuangzhen Chen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma Intestinal Low Dose Radiotherapy-1Gy, PD-1/PD-L1 inhibitors, Chemotherapy - Borderline Resectable Carcinoma, Unresectable Cancer | Phase 2 | Recruiting | Chuangzhen Chen | 39 | 2025-12-05 | 2026-10-05 |
| Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors Low-dose radiotherapy to the intestine (ILDR), PD-1/PD-L1 monoclonal antibodies - Radiotherapy, Metastatic Solid Cancers | Phase 2 | Recruiting | Chuangzhen Chen | 48 | 2025-09-26 | 2025-11-20 |
| Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Solid Tumors Intestinal Low Dose Radiotherapy-1Gy, PD-1/PD-L1 Inhibitors - Metastatic Malignant Solid Neoplasm, Radiotherapy | Phase 2 | Completed | Chuangzhen Chen | 24 | 2023-12-26 | 2026-07-30 |
| Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer gemcitabine and cisplatin - Cervical Cancer, Neoadjuvant Chemotherapy | Phase 3 | Unknown | Chuangzhen Chen | 290 | 2021-07-01 | 2024-02-06 |
| Mechanisms and Biomarkers for Tumor Immunogenicity Modulation in Cervical Cancer Cervical Cancer, Benign Tumor of Uterus | Completed | Chuangzhen Chen | 30 | 2020-12-10 | 2024-02-06 | |
| Biomarkers for Prediction of Tumor Response to Radiotherapy Solid Tumors | Recruiting | Chuangzhen Chen | 100 | 2018-10-29 | 2024-02-06 | |
| Simultaneous Modulated Accelerated Boost Versus Standard Dose Radiotherapy in Esophageal Cancer Radiotherapy with simultaneous modulated accelerated boost, Standard dose radiotherapy, PF - Esophageal Cancer | Phase 3 | Unknown | Chuangzhen Chen | 202 | 2015-08-01 | 2024-02-06 |
| Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer SMART, PF - Esophageal Neoplasms | Phase 2 | Completed | Chuangzhen Chen | 85 | 2012-08-01 | 2022-01-03 |
Esophageal Neoplasms (3) · Esophageal Squamous Cell Carcinoma (2) · Uterine Cervical Neoplasms (2) · Lung Neoplasms (1) · Neoplasm Metastasis (1)
Cisplatin (2) · Immune Checkpoint Inhibitors (2) · Drug Therapy (1) · Fluorouracil (1) · Gemcitabine (1) · Radiotherapy (1) · Surgical Procedures, Operative (1)
China (8)